主催: 公益社団法人日本薬理学会
会議名: 第96回日本薬理学会年会
回次: 96
開催地: 横浜
開催日: 2022/11/30 - 2022/12/03
Indoor air quality (IAQ) has been suggested to affect respiratory diseases. Large amounts of volatile organic compounds (VOCs), emitted from indoor building materials, are known to cause healthy people to induce sick building syndrome., thereby being regulated as an IAQ guideline. However, the effects of VOCs below the IAQ guideline values on disease pathogenesis have not been adequately studied. If indoor VOCs affect disease development, they may also influence the treatment of respiratory diseases. In this study, we aimed to clarify the effects of indoor VOCs on the diseases of allergic asthma and acute lung injury (ALI) in model mice. We compared the pathological conditions of mice exposed to indoor air containing VOCs below the guideline values and those exposed to clean air whose VOCs were removed by a chemical filter. In addition, we compared the animal experimental environment with the clinical environment by collecting the IAQ data from the mouse breeding environment and the medical facility.
Our results indicated that clean air exposure significantly improved SpO2, histological abnormalities, and gene expression of pro-inflammatory cytokines in asthma and ALI models. Our findings suggest that indoor VOCs even below the guideline values can influence the lung and immune function in asthma and ALI.